株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の整形外科用バイオマテリアル市場

Global Orthopedic Biomaterials Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 312926
出版日 ページ情報 英文 95 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
世界の整形外科用バイオマテリアル市場 Global Orthopedic Biomaterials Market 2014-2018
出版日: 2014年09月17日 ページ情報: 英文 95 Pages
概要

当レポートは、整形外科用バイオマテリアルの世界市場を取り上げ、業界の多くの専門家から得たデータ、情報とともに詳細な市場分析を提供しています。整形外科用バイオマテリアル市場は同種骨移植、機械加工骨、脱灰骨基質、骨形成タンパク質、関節液補充、幹細胞療法、人工骨置換の7分野に分類でき、これらの分野別の市場分析ならびに今後の市場予測を行っています。また地域市場別の市場分析および将来予測も示しています。

第1章 エグゼクティブ・サマリー

第2章 略語表

第3章 当レポートのカバー範囲

  • 市場概要
  • 提供製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 序論

第6章 市場状況

  • 市場概要
  • 市場規模および将来予測
  • ファイブフォース分析

第7章 素材別市場分類

第8章 製品別市場分類

第9章 同種骨移植世界市場

  • 市場概要
  • 市場規模および将来予測

第10章 機械加工骨世界市場

  • 市場概要
  • 市場規模および将来予測

第11章 脱灰骨基質(DBM)世界市場

  • 市場概要
  • 市場規模および将来予測

第12章 骨形成タンパク質(BMP)世界市場

  • 市場概要
  • 市場規模および将来予測

第13章 関節液補充療法世界市場

  • 市場概要
  • 市場規模および将来予測

第14章 幹細胞療法世界市場

  • 市場概要
  • 市場規模および将来予測

第15章 人工骨置換世界市場

  • 市場概要
  • 市場規模および将来予測

第16章 地域別市場分析

  • 南北アメリカの整形外科用バイオマテリアル市場
    • 市場規模および将来予測
  • 欧州、中東、およびアフリカ地域の整形外科用バイオマテリアル市場
    • 市場規模および将来予測
  • アジア太平洋地域の整形外科用バイオマテリアル市場
    • 市場規模および将来予測

第17章 購入基準

第18章 市場成長促進要因

第19章 市場成長促進要因とそれによる影響

第20章 市場の課題

第21章 市場成長促進要因と市場の課題とがもたらす影響

第22章 市場動向

第23章 市場動向とそれによる影響

第24章 ベンダー状況

  • 市場競争シナリオ
    • 重要ニュース
    • 企業M&A
  • 市場シェア分析
  • その他の重要ベンダー

第25章 主要ベンダー分析

  • Biomet
  • DePuy Synthes
  • Medtronic
  • Stryker
  • Wright Medical
  • Zimmer Holdings

第26章 関連レポート

目次
Product Code: IRTNTR4124

About Orthopedic Biomaterial

Orthopedic biomaterial deals with the physical and chemical properties of the material that is implanted into the human body as constituents of devices. The material implanted is designed to perform specific biological functions by substituting or repairing the damaged tissues such as cartilage, bone, ligaments, and tendons. Bone and joint-related degenerative problems affect millions of people worldwide; this is one of the major causes for half of all chronic diseases in people aged above 50 globally. Diseases and conditions in orthopedic such as osteoporosis, arthritis, tumors, trauma, hip and knee replacement, fractures, neck problems, and soft tissue injuries are the main reasons for using temporary, permanent, or biodegradable devices. Therefore, orthopedic biomaterials play a vital role in the implantation of such devices and provide beneficial objective for physiological requirements with the complex interplay of materials properties.

TechNavio's analysts forecast the Global Orthopedic Biomaterials market to grow at a CAGR of 10.78 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Orthopedic Biomaterials market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following seven products:

  • Bone allografts
  • Machined bones
  • Demineralized Bone Matrix (DBM)
  • Bone Morphogenetic Protein (BMP)
  • Viscosupplementation
  • Stem cell therapy
  • Synthetic bone substitute

TechNavio's report, the Global Orthopedic Biomaterials Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Orthopedic Biomaterials market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Biomet
  • DePuy Synthes
  • Medtronic
  • Stryker
  • Wright Medical Group
  • Zimmer Holdings

Other Prominent Vendors

  • Cam Bioceramics
  • Ceradyne
  • CeramTec
  • DSM Biomedical
  • Evonik Industries
  • Landec
  • Ulbrich Stainless Steels & Special Metals

Market Driver

  • Increase IN Aging Population

For a full, detailed list, view our report

Market Challenge

  • Fatigue, Fracture, and Wear Problems

For a full, detailed list, view our report

Market Trend

  • Advancement in Technologies

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Material

08. Market Segmentation by Product

09. Global Bone Allografts Market

  • 09.1. Market Overview
  • 09.2. Market Size and Forecast

10. Global Machined Bones Market

  • 10.1. Market Overview
  • 10.2. Market Size and Forecast

11. Global DBM Market

  • 11.1. Market Overview
  • 11.2. Market Size and Forecast

12. Global BMP Market

  • 12.1. Market Overview
  • 12.2. Market Size and Forecast

13. Global Viscosupplementation Market

  • 13.1. Market Overview
  • 13.2. Market Size and Forecast

14. Global Stem Cell Therapy Market

  • 14.1. Market Overview
  • 14.2. Market Size and Forecast

15. Global Synthetic Bone Substitute Market

  • 15.1. Market Overview
  • 15.2. Market Size and Forecast

16. Geographical Segmentation

  • 16.1. Orthopedic Biomaterials Market in the Americas
    • 16.1.1. Market Size and Forecast
  • 16.2. Orthopedic Biomaterials Market in EMEA
    • 16.2.1. Market Size and Forecast
  • 16.3. Orthopedic Biomaterials Market in APAC
    • 16.3.1. Market Size and Forecast

17. Buying Criteria

18. Market Growth Drivers

19. Drivers and their Impact

20. Market Challenges

21. Impact of Drivers and Challenges

22. Market Trends

23. Trends and their Impact

24. Vendor Landscape

  • 24.1. Competitive Scenario
    • 24.1.1. Key News
    • 24.1.2. Mergers and Acquisitions
  • 24.2. Market Share Analysis 2013
  • 24.3. Other Prominent Vendors

25. Key Vendor Analysis

  • 25.1. Biomet
    • 25.1.1. Key Facts
    • 25.1.2. Business Overview
    • 25.1.3. Product Segmentation by Revenue 2014
    • 25.1.4. Products Segmentation by Revenue 2013 and 2014
    • 25.1.5. Geographical Segmentation by Revenue 2014
    • 25.1.6. Business Strategy
    • 25.1.7. Recent Developments
    • 25.1.8. SWOT Analysis
  • 25.2. DePuy Synthes
    • 25.2.1. Key Facts
    • 25.2.2. Business Overview
    • 25.2.3. Business Units
    • 25.2.4. Business Strategy
    • 25.2.5. Recent Developments
    • 25.2.6. SWOT Analysis
  • 25.3. Medtronic
    • 25.3.1. Key Facts
    • 25.3.2. Business Overview
    • 25.3.3. Business Segmentation by Revenue 2013
    • 25.3.4. Business Segmentation by Revenue 2012 and 2013
    • 25.3.5. Geographical Segmentation by Revenue 2013
    • 25.3.6. Business Strategy
    • 25.3.7. Recent Developments
    • 25.3.8. SWOT Analysis
  • 25.4. Stryker
    • 25.4.1. Key Facts
    • 25.4.2. Business Overview
    • 25.4.3. Business Segmentation by Revenue 2013
    • 25.4.4. Business Segmentation by Revenue 2012 and 2013
    • 25.4.5. Geographical Segmentation by Revenue 2013
    • 25.4.6. Business Strategy
    • 25.4.7. Recent Developments
    • 25.4.8. SWOT Analysis
  • 25.5. Wright Medical
    • 25.5.1. Key Facts
    • 25.5.2. Business Overview
    • 25.5.3. Product Segmentation by Revenue 2013
    • 25.5.4. Product Segmentation by Revenue 2012 and 2013
    • 25.5.5. Geographical Segmentation by Revenue 2013
    • 25.5.6. Business Strategy
    • 25.5.7. Recent Developments
    • 25.5.8. SWOT Analysis
  • 25.6. Zimmer Holdings
    • 25.6.1. Key Facts
    • 25.6.2. Business Overview
    • 25.6.3. Business Segmentation by Revenue 2013
    • 25.6.4. Business Segmentation by Revenue 2012 and 2013
    • 25.6.5. Geographical Segmentation by Revenue 2013
    • 25.6.6. Business Strategy
    • 25.6.7. Recent Developments
    • 25.6.8. SWOT Analysis

26. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Orthopedic Biomaterials Market 2013-2018 in (US$ million)
  • Exhibit 3: Global Orthopedic Biomaterials Market Segmentation by Materials
  • Exhibit 4: Global Orthopedic Biomaterials Market Segmentation by Product
  • Exhibit 5: Global Orthopedic Biomaterials Market Segmentation by Product Segment 2013-2018 in (US$ million)
  • Exhibit 6: Global Orthopedic Biomaterials Market Segmentation by Product Segment in 2013-2018
  • Exhibit 7: Global Bone Allografts Market 2013-2018 (US$ million )
  • Exhibit 8: Global Machined Bones Market 2013-2018 (US$ million )
  • Exhibit 9: Global DBM Market 2013-2018 (US$ million )
  • Exhibit 10: Global BMP Market 2013-2018 (US$ million )
  • Exhibit 11: Global Viscosupplementation Market 2013-2018 (US$ million )
  • Exhibit 12: Global Stem Cell Therapy Market 2013-2018 (US$ million )
  • Exhibit 13: Global Synthetic Bone Substitute Market 2013-2018 (US$ million )
  • Exhibit 14: Global Orthopedic Biomaterials Market Segmentation Revenue by Products in 2013
  • Exhibit 15: Global Orthopedic Biomaterials Market by Geographical Segmentation in 2013
  • Exhibit 16: Orthopedic Biomaterials Market in the Americas(US$ million)
  • Exhibit 17: Orthopedic Biomaterials Market in EMEA (US$ million)
  • Exhibit 18: Orthopedic Biomaterials Market in EMEA (US$ million)
  • Exhibit 19: Biomet: Product Segmentation by Revenue 2014
  • Exhibit 20: Biomet: Product Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 21: Biomet: Geographical Segmentation by Revenue 2014
  • Exhibit 22: DePuy Synthes: Business Units
  • Exhibit 23: Medtronic: Business Segmentation by Revenue 2013
  • Exhibit 24: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 25: Medtronic: Geographical Segmentation by Revenue 2013
  • Exhibit 26: Stryker: Business Segmentation by Revenue 2013
  • Exhibit 27: Stryker: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 28: Stryker: Geographical Segmentation by Revenue 2013
  • Exhibit 29: Wright Medical: Product Segmentation by Revenue 2013
  • Exhibit 30: Wright Medical: Product Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 31: Wright Medical: Geographical Segmentation by Revenue 2013
  • Exhibit 32: Global Orthopedic Biomaterials market: Business Segmentation by Revenue 2013
  • Exhibit 33: Global Orthopedic Biomaterials market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 34: Global Orthopedic Biomaterials market: Geographical Segmentation by Revenue 2013
Back to Top